trending Market Intelligence /marketintelligence/en/news-insights/trending/hatxnlv4tpf6zy7u7fyr9g2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Cancer Genetics gets Nasdaq noncompliance notice

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Cancer Genetics gets Nasdaq noncompliance notice

Rutherford, N.J.-based Cancer Genetics Inc. said it failed to comply with Nasdaq's $1 minimum bid price per share for its common shares.

The biotechnology company, which develops molecular and biomarker-based tests and services, has 180 calendar days, or until Feb. 4, 2019, to regain compliance.